等待開盤 03-26 09:30:00 美东时间
0.000
0.00%
BTIG suspends Neutral rating on Exact Sciences (NASDAQ:EXAS).
03-24 17:59
As previously communicated, this transaction is expected to add approximately $3 billion of incremental sales in 2026, accelerate Abbott's 2026 sales growth by approximately 0.5% and dilute 2026 adjusted earnings per
03-20 21:05
Abbott to close Exact Sciences acquisition on March 23, 2026 Abbott’s acquisition of Exact Sciences is expected to close on March 23, 2026, following receipt of all regulatory clearances necessary for closing. The deal adds Exact Sciences’ cancer screening and diagnostics portfolio, including Cologu
03-20 21:01
Amalgam Rx, Inc., a leader in data-driven, AI-powered healthcare engagement and clinical decision support, today announced results from a Privia Health (NASDAQ: PRVA)-led colorectal cancer (CRC) screening program,
03-03 23:05
Earnings Call Insights: Quanterix Corporation (QTRX) Q4 2025 Management View Everett Cunningham, President and CEO, introduced himself to investors, emphasizing his background in healthcare and commer...
03-03 17:08
At the special meeting, preliminary results showed that more than 99% of the votes cast, representing approximately 67% of the total outstanding shares of Exact Sciences common stock as of the January 9, 2026 record date
02-21 05:06
Abbott Laboratories (ABT) declares $0.63/share quarterly dividend, in line with previous. Forward yield 2.26% Payable May 15; for shareholders of record April 15; ex-div April 15. See ABT Dividend Sco...
02-21 01:29
经济观察网 基于最新公开信息,精密科学(EXAS)近期值得关注的事件主要包括以下方面: 股票近期走势 2026年2月6日,精密科学成交额达4.90亿美元,较前一...
02-20 02:53
索罗斯旗下的索罗斯基金管理公司在第四季度的投资组合中进行了显著调整,重点增持了科技巨头,并对能源与加密概念股进行了“高抛低吸”的操作。
02-14 11:23
华盛资讯2月14日讯,精密科学公布2025财年Q4业绩,公司Q4营收8.78亿美元,同比增长23.1%,归母净利润亏损0.86亿美元,同比亏损缩窄90.1%。
02-14 06:17